Inventor · disambiguated record
Hanif Ali
Also filed as: ALI HANIF
3 granted patents·11 pending applications·19 citations·filing 2014–2023
65Inventor score
Top patents by PatentIndex Score
14 records- 0191US10667501B2Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulinsKYMAB LTD·Filed 2014·Granted Jun 2, 2020·15 cites·6 claims
- 0288US2024200054A1Methods, cells & organismsKYMAB LTD·Filed 2023·Application pending·0 cites
- 0375US11920128B2Methods, cells and organismsKYMAB LTD·Filed 2019·Granted Mar 5, 2024·0 cites·19 claims
- 0475US11453726B2Multimers, tetramers and octamersQUADRUCEPT BIO LTD·Filed 2017·Granted Sep 27, 2022·4 cites·25 claims
- 0564US2017275611A1Methods, cells & organismsKYMAB LTD·Filed 2017·Application pending·0 cites
- 0663US2016177340A1Methods, Cells & OrganismsKYMAB LTD·Filed 2016·Application pending·0 cites
- 0761US2016207983A1Methods, Cells & OrganismsKYMAB LTD·Filed 2016·Application pending·0 cites
- 0861US2016257948A1Methods, Cells & OrganismsKYMAB LTD·Filed 2016·Application pending·0 cites
- 0961US2015079680A1Methods, cells & organismsKYMAB LTD·Filed 2014·Application pending·0 cites
- 1060US2016257974A1Methods, Cells & OrganismsKYMAB LTD·Filed 2016·Application pending·0 cites
- 1158US2020267952A1Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulinsKYMAB LTD·Filed 2020·Application pending·0 cites
- 1253US2023183378A1Multimers, tetramers & octamersQUADRUCEPT BIO LTD·Filed 2022·Application pending·0 cites
- 1347US2023250156A1Multimers for viral strain evolutionQUADRUCEPT BIO LTD·Filed 2021·Application pending·0 cites
- 1443US2022162285A1MultimersQUADRUCEPT BIO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hanif Ali files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →